Exyte has completed the acquisition of US-based CollabraTech Solutions, a specialist in delivery systems and contract manufacturing services for hi-tech industries.
Exyte is a design, engineering, and delivery expert for high-tech facilities.
Both parties have agreed not to disclose the details of the purchase agreement.
With the acquisition of CollabraTech Solutions, Exyte advances its strategy of vertical integration, strengthening the business in the area of mission-critical equipment and installation services.
Exyte's Technology & Services (T&S) business area consists of companies that provide cleanroom technology, mission-critical subsystems, and installation services.
Acquisitions as part of the "Next Level" future agenda
Exyte is successfully pursuing its "Pathway to Ten", aiming to achieve sales of ten billion Euros by 2027 at the latest.
To this end, the company has defined the future agenda "Next Level".
Sales are expected to further increase in all business segments, including strategic acquisitions.
CollabraTech Solutions is the fourth acquisition to strengthen Exyte’s Technology & Services business area, following the acquisitions of US-based, Critical Process Systems Group (CPS) and Airgard, as well as the Germany-based Intega.
With these acquisitions, Germany-based, Exyte expanded its portfolio to include delivery systems and exhaust gas management, among others, for industries like semiconductors and life sciences.
Exyte is successfully pursuing its "Pathway to Ten"
Dr Wolfgang Büchele, CEO of Exyte, said: “Through the acquisition of highly specialised companies, we bring complementary technology, experience, and value creation into our company, while also unlocking additional revenue opportunities.”
“The strategic advancement of T&S supports our profitable growth," Dr Büchele concluded.
Steve Lemons, President of CollabraTech Solutions, said: “With Exyte, CollabraTech Solutions gains a team who will support and promote our long-term development.”
“With its leadership position in the design and delivery of high-tech manufacturing facilities, Exyte is well-regarded in our target markets,” Lemons continued.
“The company understands the complexity of our products and the technical requirements of our industries. With Exyte, we can maximise our growth from the various planned investments in semiconductor facilities and provide industry-leading solutions to our customers," Lemons concluded.